Resectable Locally Advanced Non-small Cell Lung Cancer
1 clinical trials · Condition
◉ Watch Resectable Locally Advanced Non-small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043) (NCT04846634) | Tianjin Medical University Cancer Institute and Hospital | 2021-08-01 |
Track Resectable Locally Advanced Non-small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.